EUVIMEDEUVIMED entdecken
VergleichsstudieÄquivalenzstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Vascular Healing After Biodegradable Polymer Sirolimus‐Eluting Versus Durable Polymer Everolimus‐Eluting Stents in Chronic Total Occlusions

Geng Wang, Yi Li, Wen Lu, Yawei Xu, Xi Su, Shaoliang Chen iD, Yang Li iD, Yaling Han iD, TARGET CTO OCT substudy Investigators

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31423 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Geng Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Frigid Zone Cardiovascular Diseases, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Nort…. Hauptthemen laut MEDLINE: Absorbable Implants, Cardiovascular Agents, Coronary Occlusion, Drug-Eluting Stents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The trial was funded by Liaoning Province Science and Technology plan joint project (Grant 2023JH2/101700126) and a research grant from Shanghai MicroPort Medi….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biodegradable polymer stents may reduce the risk of neoatherosclerosis and stent thrombosis. Limited data is available for biodegradable polymer sirolimus‐eluting stent (BP‐SES) and durable polymer drug‐eluting stents (DP‐EES) in chronic total occlusions (CTO).

Aim

This study was to evaluate healing patterns of BP‐SES versus DP‐EES in CTO at 3 and 13 months based on optical coherence tomography (OCT).

Methods

The TARGET‐CTO study is a prospective, multicenter, randomized noninferiority controlled trial for BP‐SES compared to DP‐EES in CTO. In the current predefined subanalysis, 44 consecutive patients underwent OCT follow‐up at 3 and 13 months. The primary endpoint was mean neo‐intimal thickness at 3 months.

Results

At 3 months, mean neo‐intimal thickness was 47.6 ± 15.7 µm in BP‐SES and 62.5 ± 37.3 µm in DP‐EES ( p = 0.384), meeting the noninferiority for BP‐SES ( p noninferiority < 0.001). Mean neo‐intimal thickness at 13 months was 76.4 ± 34.1 µm in BP‐SES and 106.6 ± 54.9 µm in DP‐EES ( p = 0.086). No significant differences in strut coverage were observed at 3 or 13 months. At 13 months significantly higher percentages of frames with layered neo‐intima and neoatherosclerosis were observed in DP‐EES compared to BP‐SES ( p = 0.015 and p = 0.021, respectively).

Conclusions

BP‐SES was noninferior to DP‐EES in terms of neo‐intimal thickness at 3 months and healing responses at 3‐month follow‐up were comparable. At 13 months, less advanced neoatherosclerosis patterns were observed in BP‐SES as compared to DP‐EES.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Absorbable ImplantsCardiovascular AgentsCoronary OcclusionDrug-Eluting StentsEverolimusPercutaneous Coronary InterventionSirolimusAgedFemaleHumansMaleMiddle AgedChronic DiseaseCoronary VesselsNeointimaPolymersProspective StudiesProsthesis DesignTime FactorsTomography, Optical CoherenceTreatment OutcomeWound Healing

Stichwörter der Autor:innen

neoatherosclerosisoptical coherence tomographyvascular healing

Substanzen

Cardiovascular AgentsEverolimusPolymersSirolimus

Autor:innen und Institutionen

  • State Key Laboratory of Frigid Zone Cardiovascular Diseases, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
  • Department of Cardiology, Xuzhou Central Hospital, Xuzhou, China.
  • Department of Cardiology, Shanghai Tenth People's Hospital, Shanghai, China.
  • Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan, China.
  • Department of Cardiology, Nanjing First Hospital, Nanjing, China.

ORCID-Profile: Shaoliang Chen, Yang Li, Yaling Han

Förderung

  • The trial was funded by Liaoning Province Science and Technology plan joint project (Grant 2023JH2/101700126) and a research grant from Shanghai MicroPort Medi…

Zitieren

APA

Wang, G., Li, Y., Lu, W., Xu, Y., Su, X., Chen, S., Li, Y., Han, Y., & TARGET CTO OCT substudy Investigators (2025). Vascular Healing After Biodegradable Polymer Sirolimus‐Eluting Versus Durable Polymer Everolimus‐Eluting Stents in Chronic Total Occlusions. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31423

Vancouver

Wang G, Li Y, Lu W, Xu Y, Su X, Chen S, et al. Vascular Healing After Biodegradable Polymer Sirolimus‐Eluting Versus Durable Polymer Everolimus‐Eluting Stents in Chronic Total Occlusions. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31423

BibTeX
@article{Wang2025,
  author = {Wang, Geng and Li, Yi and Lu, Wen and Xu, Yawei and Su, Xi and Chen, Shaoliang and Li, Yang and Han, Yaling and TARGET CTO OCT substudy Investigators, TARGET CTO OCT substudy Investigators},
  title = {Vascular Healing After Biodegradable Polymer Sirolimus‐Eluting Versus Durable Polymer Everolimus‐Eluting Stents in Chronic Total Occlusions},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31423}
}
Kostenlos starten →